Anuradha Banerjee, MD
University of California, San Francisco · University of California at San Francisco
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Anuradha Banerjee, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:39 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT02116959 · Alternating Systemic Chemotherapy and Intra-Arterial Melphalan (IAM) Chemotherapy in Children With Intra-Ocular RetinoblastomaUniversity of California, San Francisco · terminated · Advanced Intra-Ocular Retinoblastoma, Retinoblastoma · principal investigator
- Ph1/Ph2NCT00378235 · Phase I/II Trial of Intracerebral IL13-PE38QQR Infusions in Pediatric Patients With Recurrent Malignant GliomaINSYS Therapeutics Inc · withdrawn · Recurrent Malignant Glioma · principal investigator
- Ph1/Ph2NCT00053040 · Immunotoxin Therapy in Treating Children With Recurrent Malignant GliomasPediatric Brain Tumor Consortium · withdrawn · Brain and Central Nervous System Tumors · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:39 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.